NCT05318794View on ClinicalTrials.gov

Neoadjuvant Systemic and Peritoneal Chemotherapy for Advanced Gastric Cancer

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

November 30, 2023

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2030

Conditions
Gastric CancerPeritoneal MetastasesChemotherapy Effect
Interventions
DRUG

Doxorubicin and Cisplatin

Pressurised intraperitoneal aerosol chemotherapy

Trial Locations (1)

W12 0HS

Imperial College London, Hammersmith Hospital Campus, London

All Listed Sponsors
lead

Imperial College London

OTHER

NCT05318794 - Neoadjuvant Systemic and Peritoneal Chemotherapy for Advanced Gastric Cancer | Biotech Hunter | Biotech Hunter